Global Age Related Macular Degeneration Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Age Related Macular Degeneration Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Age Related Macular Degeneration Treatment market is projected to reach US$ 9592.7 million in 2033, increasing from US$ 7725.7 million in 2022, with the CAGR of 2.8% during the period of 2023 to 2033. Demand from Hospital and Clinic are the major drivers for the industry.
The age-related macular degeneration (AMD) treatment market is driven by the increasing prevalence of AMD, particularly in the aging population. As the global elderly population grows, the demand for effective treatment options to manage and slow down AMD progression rises. Additionally, advancements in medical research and technology have led to the development of novel therapies, such as anti-VEGF drugs, which have significantly improved visual outcomes for AMD patients. However, challenges exist, including the high cost of treatment, especially for long-term therapies, and the need for early detection and diagnosis to ensure timely intervention. Overcoming these challenges through affordable treatment options, patient education, and continued research to identify new therapeutic targets will be crucial for the sustained growth of the age-related macular degeneration treatment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Age Related Macular Degeneration Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Segment by Type
Lucentis
Eylea
Avastin
Other
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Age Related Macular Degeneration Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Age Related Macular Degeneration Treatment introduction, etc. Age Related Macular Degeneration Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Age Related Macular Degeneration Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Age Related Macular Degeneration Treatment report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Age Related Macular Degeneration Treatment market is projected to reach US$ 9592.7 million in 2033, increasing from US$ 7725.7 million in 2022, with the CAGR of 2.8% during the period of 2023 to 2033. Demand from Hospital and Clinic are the major drivers for the industry.
The age-related macular degeneration (AMD) treatment market is driven by the increasing prevalence of AMD, particularly in the aging population. As the global elderly population grows, the demand for effective treatment options to manage and slow down AMD progression rises. Additionally, advancements in medical research and technology have led to the development of novel therapies, such as anti-VEGF drugs, which have significantly improved visual outcomes for AMD patients. However, challenges exist, including the high cost of treatment, especially for long-term therapies, and the need for early detection and diagnosis to ensure timely intervention. Overcoming these challenges through affordable treatment options, patient education, and continued research to identify new therapeutic targets will be crucial for the sustained growth of the age-related macular degeneration treatment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Age Related Macular Degeneration Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Segment by Type
Lucentis
Eylea
Avastin
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Age Related Macular Degeneration Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Age Related Macular Degeneration Treatment introduction, etc. Age Related Macular Degeneration Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Age Related Macular Degeneration Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices